Literatur

Potential benefit of probiotic E. coli Nissle in term neonates.

In: Klin. Padiatr. 235 (4), S. 213–220. DOI: 10.1055/a-1970-4340.

Weitere Veröffentlichungen:

Clostridioides difficile-assoziierte Diarrhö – Klinische Studie zur adjuvanten Therapie mit Saccharomyces boulardii

Weitere Informationen

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Weitere Informationen

NF-KappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917. A novel effect of a probiotic bacterium.

Weitere Informationen

Olbertz, Dirk; Proquitté, Hans; Patzer, Ludwig; Erler, Thomas; Mikolajczak, Alexsandra; Sadowska-Krawczenko, Iwona et al. (2023): Potential benefit of probiotic E. coli Nissle in term neonates.